Skip to main content

Day: February 26, 2025

Full year results: Outstanding 2024 – strong increases in turnover and profit, positive net cash, unmatched orderbook

Highlights financial year 2024Orderbook stands at 8.2 billion euro at the end of the year, up from 7.6 billion euro a year ago Group turnover grew 25% year-over-year to 4.1 billion euro, with solid growth in all contracting segments EBITDA rose 28% reaching 764 million euro, or 18.6% of turnover, up from 596 million euro, or 18.2% of turnover for 2023 Net profit increased by 77%, reaching 288 million euro, compared to 163 million euro a year ago Unprecedented free cash flow generation in 2024, amounting to 729 million euro; resulting in a net cash position of 91 million euro at year-end from a net financial debt of 512 million euro at the end of 2023 Proposal for a gross dividend of 3.8 euro per share, compared to 2.1 euro a year agoAttachmentP2025 DEME 2024 results ENG

Continue reading

JDE Peet’s reports full-year results 2024

JDE Peet’s delivered strong 2024 results, exceeding elevated H1 guidance Increases shareholder returns through higher dividend and multi-year share buyback plan PRESS RELEASE Amsterdam, 26 February 2025 Key items1Organic sales up +5.3%, driven by 4.5% price and 0.7% volume/mix; Reported sales up 7.9% Organic adjusted gross profit up +6.1%; Reported gross profit up +7.9% Organic adjusted EBIT up +10.4% to EUR 1.3 billion Free cash flow of EUR 1,044 million; Net leverage at 2.7x Proposal to increase cash dividend by 4.3% to EUR 0.73 per share Intention to launch multi-year share buyback programme of up to EUR 1 bn, with EUR 250 mln in 2025A message from Rafa Oliveira, CEO of JDE Peet’s “We are very pleased with this strong set of broad-based results, especially considering the increased green coffee inflation. Innovation, driven...

Continue reading

BTS Group AB (publ) Year end report January – December 2024

  P R E S S  R E L E A S E Stockholm, February 26, 2025 Rebound continued for BTS Europe and good momentum for our AI tools October 1 – December 31, 2024Net sales MSEK 796 (768). Currency adjusted growth 3%, whereof 0% was organic. EBITA –2%, MSEK 136 (139). EBITA margin 17.0 (18.1) %. Profit after tax amounted to MSEK 84 (110). Excluding reversed provisions of earn-out, the profit after tax increased 1 percent to 82 (81). 1) Earnings per share amounted to SEK 4.31 (5.66). 2) Excluding reversed provision of earn-out, earnings per share increased 1% to SEK 4.24 (4.20). 1)January 1 – December 31, 2024Net sales MSEK 2,802 (2,683). Currency adjusted growth +5%, whereof 3% was organic. EBITA +6 %, MSEK 365 (346). EBITA margin 13.0 (12.9) %. Profit after tax amounted to MSEK 387 (215). Excluding reversed provision of earn-out, the profit...

Continue reading

Worldline FY 2024 RESULTS

FY 2024 RESULTSRefocus and rebound underway FY24 results€4,632m revenue, +0.5% organic growth, of which +1.9% in Merchant Services€1,070m adjusted EBITDA€201m free cash-flow, or 19% adjusted EBITDA conversion rate€434m Normalized Net Income group share€(297)m reported Net Income group share1 2025: leveraging Worldline’s repositioning to start the rebound New product developments to accelerate in H2’25with renewed leadership team in MSStrict focus on cost control while leveraging Power24 to improve unlevered free cash flowPortfolio pruning well underway Solid balance sheet and liquidity profileActive management of debt maturity profile while maintaining strong liquidity (successful issuance of a €500m 5-year bond and RCF maturity extended) Worldline appoints Pierre-Antoine Vacheron as Chief Executive Officer30 years of extensive experience...

Continue reading

KALDVIK AS (KLDVK): Q4 2024 Results

KALDVIK AS (KLDVK) reports Operating income in Q4 amounted to EURm 46.8 (EURm 32.6), while the operating profit/loss before fair value adjustment of biomass and production tax was EURm -18.1 (EURm 4.6). Operating profit/loss before fair value adjustment of biomass, one-off biomass write-down and production tax was EURm 5.0 (EURm 4.6). Harvest amounted to 6.668 tonnes in Q4 2024 (4.202 tonnes) Web cast will be at 11:00 (CET)/ 10:00 Icelandic time on 26 February 2025 on the following link: www.kaldvik.is/live Attached is the presentation and report for Q4 2024. Kaldvik, 26 February 2025 Contacts: Robert Robertsson, CFO of KALDVIK AS: +354 843 0086(mobile) This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentsKaldvik AS – Q4 2024 Quarterly...

Continue reading

Idorsia reaches an agreement with significant bondholders to restructure its convertible bond debt and to secure funding for future operations

Ad hoc announcement pursuant to Art. 53 LRMore than the required two-thirds majority of bondholders reach agreement on the main terms for the restructuring of Idorsia’s outstanding convertible bond debt – allowing the removal of a large debt overhang and providing CHF 150 million of new funding Agreement with Viatris to revise collaboration for selatogrel and cenerimod results in the removal of significant cash requirement for 2025 Release from exclusivity constraint allows Idorsia to pivot to negotiate with alternative parties for the global rights to aprocitentan Idorsia to host an investor webcast today, at 15:00 CET Full Year 2024 Financial Reporting and publication of the Financial Report to be postponed to March 4, 2025Allschwil, Switzerland – February 26, 2025Idorsia Ltd (SIX: IDIA) today announced that it has reached an agreement...

Continue reading

Bigbank’s Unaudited Financial Results for Q4 and 12 months of 2024

Bigbank’s gross loan portfolio reached a record 2.2 billion euros at the end of the year, increasing by 137 million euros (+7%) quarter on quarter and by 535 million euros (+32%) year on year. The focus product lines showed solid quarter-on-quarter growth. The business loan portfolio grew by 61 million euros (+9%) to 764 million euros and the home loan portfolio by 79 million euros (+15%) to 613 million euros. The consumer loan portfolio decreased by 9 million euros (-1%) quarter on quarter to 828 million euros. Bigbank’s deposit portfolio grew in the fourth quarter mainly through term deposits. During the quarter, the term deposit portfolio grew by 118 million euros to 1.36 billion euros (+10%) and the savings deposit portfolio by 8 million euros to 1.03 billion euros (+1%). The Group’s total deposit portfolio grew by 127 million euros...

Continue reading

Idorsia and Viatris update their collaboration for selatogrel and cenerimod

Ad hoc announcement pursuant to Art. 53 LRIdorsia’s contribution to the development costs reduced by USD 100 million Viatris potential regulatory and sales milestones payments to Idorsia reduced by USD 250 millionAllschwil, Switzerland – February 26, 2025Idorsia Ltd (SIX: IDIA) today announced that it has reached an agreement with Viatris Inc. (NASDAQ: VTRS) to update the terms of the global development and commercialization collaboration for selatogrel and cenerimod. In exchange for a USD 100 million reduction to Idorsia’s contribution to the development costs due in 2025, Idorsia has agreed to a USD 250 million reduction in future potential regulatory and sales milestone payments, and an expansion of territorial rights to Viatris for cenerimod. The agreed royalties on future sales remain unchanged. About the collaboration agreementOn...

Continue reading

Idorsia is released from exclusivity constraint regarding the global rights to aprocitentan – now pivoting to alternative parties

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – February 26, 2025Idorsia Ltd (SIX: IDIA) today announced that the exclusivity agreement signed in November 2024 with an undisclosed party for the global rights to aprocitentan has concluded without the party signing the deal as foreseen in the non-binding term sheet. Idorsia will retain the exclusivity fee of USD 35 million paid in December 2024. André C. Muller, CEO of Idorsia, commented:“It is disappointing that the undisclosed party has decided not to sign the deal contemplated for aprocitentan despite sharing our view on the quality of the asset. We need to move on, and we will resume discussions with other potential partners that recognize the blockbuster potential of aprocitentan in uncontrolled hypertension, particularly for the difficult-to-treat patients with...

Continue reading

SPX Technologies to Host Tour of Ingénia Facility on April 1, 2025

CHARLOTTE, N.C., Feb. 25, 2025 (GLOBE NEWSWIRE) — SPX Technologies Inc. (NYSE:SPXC) will host a tour of its Ingénia Technologies production facility on April 1, 2025, in Mirabel, Quebec, near Montreal. The event will be hosted by SPX’s corporate Investor Relations team and key managers of the company’s HVAC segment. The event is expected to begin mid-day and last approximately two hours in total. It will be open to current and prospective investors of SPX, as well as interested sell-side analysts. An invitation will be required to participate in the event. To receive an invitation, please contact the SPX Investor Relations team at spx.investor@spx.com. Headquartered in Mirabel, Quebec, Canada, Ingénia specializes in the design and manufacture of custom air handling units and is part of SPX Technologies’ Cooling platform, within...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.